• Latest Posts

Apceth Initiates Phase II for its pioneering Engineered Cell Therapy to treat Gastrointestinal Cancer

Epigenomics’ proColon, the non-invasive blood-based test for colorectal cancer

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

New Oncology finances its Genetic Test for Cancer Diagnosis

Promising Collaboration Between Evotec and Second Genome

ADVERTISEMENT

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

MorphoSys and Emergent BioSolutions Initiate Phase I

Baxter’s Bioscience Business Acquires SuppreMol

Boehringer Ingelheim submits applications for approval of Idarucizumab, an anti-anticoagulant

Is Pichia Pastoris the Best Protein Expression System?

AYOXXA raises its sights with a new agreement to develop ophthalmic diagnostic tools

ADVERTISEMENT